Skip to main content
Clinical Trials/IRCT20200502047269N1
IRCT20200502047269N1
Recruiting
Phase 3

Comparison of the sedative effect of Remifentanil and Dexmidetomidine in patients undergoing venous arterial fistula implantation

Iran University of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients undergoing venous arterial fistula implantation.
Sponsor
Iran University of Medical Sciences
Enrollment
32
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age group 19 to 60 years
  • Patients with stable hemodynamic status

Exclusion Criteria

  • Patients with a history of cardiovascular abnormalities
  • Patients with a history of chronic diseases such as liver disease
  • Patients with a history of allergies to anesthetics, including opioids
  • Patients with a history of opium use
  • Pregnant or lactating women
  • Recent respiratory tract infection
  • Severe bronchopulmonary disease

Outcomes

Primary Outcomes

Not specified

Similar Trials